Přejít k obsahu
Merck
  • Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.

Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.

Nanoscale (2017-07-06)
Samara R Alves Rico, Azhar Z Abbasi, Geise Ribeiro, Taksim Ahmed, Xiao Yu Wu, Denise de Oliveira Silva
ANOTACE

A unique class of diruthenium(ii,iii) metallodrugs containing non-steroidal anti-inflammatory drug (NSAID), Ru

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
Ethyl arachidate, ≥99%